Point72 Hong Kong’s Mirum Pharmaceuticals MIRM Stock Holding History

Point72 Hong Kong’s Portfolio MIRM Stock Details MIRM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$366K	Buy	+4,986	New	+$317K	0.02%	277
2025 Q2	–	Sell	-296	Closed	-$13.3K	–	616
2025 Q1	$13.3K	Buy	+296	New	+$14K	﹤0.01%	415
2022 Q2	–	Sell	-364	Closed	-$8K	–	2228
2022 Q1	$8K	Buy	364 +331	+1,003%	+$6.75K	﹤0.01%	1632
2021 Q4	$1K	Buy	+33	New	+$513	﹤0.01%	1802
2021 Q1	–	Sell	-1,104	Closed	-$19K	–	2060
2020 Q4	$19K	Buy	+1,104	New	+$21.7K	﹤0.01%	1435
2020 Q3	–	Sell	-750	Closed	-$15K	–	1394
2020 Q2	$15K	Buy	+750	New	+$12.5K	﹤0.01%	933

Other funds holding MIRM

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

NHAS

Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Point72 Hong Kong's MIRM Position: Q3 2025 in Review

Point72 Hong Kong opened a new position in Mirum Pharmaceuticals (MIRM) in Q3 2025: 4,986 shares worth $366K. The stake represents 0.02% of the portfolio and ranks #277 among its holdings. This is a return to the name: Point72 Hong Kong previously reported a position in MIRM as recently as Q1 2025.

Point72 Hong Kong first reported a position in MIRM in Q2 2020 and has held it in 6 quarters since. 272 funds tracked by Wall St. Rank hold MIRM as of Q3 2025.

Point72 Hong Kong held 4,986 shares of Mirum Pharmaceuticals worth $366K as of Q3 2025.
Mirum Pharmaceuticals was a new Point72 Hong Kong position in Q3 2025.
Mirum Pharmaceuticals made up 0.02% of Point72 Hong Kong's portfolio in Q3 2025, its #277 holding.
Point72 Hong Kong first reported a position in Mirum Pharmaceuticals in Q2 2020 and has held it in 6 quarters since.
272 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q3 2025.

Based on Point72 Hong Kong's 13F filing for Q3 2025, filed 14 Nov 2025.